Sun Pharma owns approx 76% on a diluted basis of the outstanding common shares of Caraco. . leading pharmacy company in India. Sun Pharma has two R&D centers in Baroda and Mumbai.Chronic Therapy Startup with just 5 products in 1983 Sales were initially limited to 2 states West Bengal and Bihar. Headquarter in Mumbai.

 60% of sales from international markets. Sun Pharma was listed on the main stock exchanges in India in 1994. 140/.49 mill for the year ending March 09.222 mill with a profit of Rs.  2 World class research centers. 10 face value equity share at a premium of Rs.  8000 employees.  The Rs 55 crore issue of a Rs.  It currently markets 58 products and had reported a turnover of Rs.was oversubscribed 55 times. .

.

4 21.3 30.8 818 38 1765 6485 3541 2543 6565 18595 .7 74.4 35.7 87.6 26.9 41.Particular 20012002 7552 20022003 9812 20032004 9995 20042005 12301 20052006 18042 20062007 23745 20072008 35017 20082009 44808 Total income Profit after tax 1707 2444 3446 4002 5630 8402 15509 18780 Reserve and surplus Earning per share( in rupees) Investment 4596 5141 7540 10366 14959 26747 48879 69414 35.

00 18740 16225.5 15099.5 15099.8 13.9 41040.00 4500.1 15099.1 RS IN MILLION RS IN MILLION 31st MARCH 08 RS IN MILLION RS IN MILLION 259.6 .9 50478.31STMARCH 09 RESERVES AND SURPLUS Capital reserveAs per last balance sheet Securities premium Account As per last balance sheet Add-received during the year Capital redemption reserve As per last balance sheet Add transferred from profit and loss account General reserve As per last balance sheet Add transferred from profit and loss account Surplus as per profit and loss A/c 14240.6 154.5 154.7 154.1 11240 3000 14240 11287.9 9933.1 5165.1 259.2 140.

.

2009 40437 12653 0 31st march. 2009. (Rs. 5 each Book value per equity share of Rs.Your Directors take pleasure in presenting the Seventeenth Annual Report and Audited Accounts for the year ended 31st March.5 each 2848 484 4500 13.50 203 .2008 32767 10140 1 Dividend on equity share Corporate dividend tax Transfer to various reserves Amount of dividend per equity share of Rs.75 249 2175 372 3014 10. in million except book value and dividend per share) Financial results Total income Profit after tax Dividend on preference share 31st march.

10. 2009.DIVIDEND Your Directors are pleased to recommend an equity dividend of Rs.13.5/.50 per equity share of face value Rs. .5/.75 per equity share of face value Rs.each (previous year Rs.each)for the year ended 31st March.

to the equity share holders.  187. without payment being received in cash.BONUS SHARES  161.177.1 each allotted as fully paid bonus shares. Amalgamation Reserve and Capital Redemption Reserve Account. by capitalization of Capital Redemption reserve. .630.010 Equity shares were allotted as fully paid Bonus Shares by capitalization of Securities Premium Account. Profit and Loss Account.232 6% Cumulative Redeemable Preference Shares of Re.

NET WORTH NET WORTH 8596 6962 5356 4654 3647 3093 2177 929 1271 1695 .

.

.

7 (3.7) Year ended 31st March.540.1 .6 9.603.434.9 (60. 2008 Rs in Million 10.773.5 6.6) Cash and cash equivalent at the end of the year 12.CASH FLOW STATEMENT FOR THE YEAR ENDED 31st MARCH 2009 Year ended 31st March. 2008 Rs in Million Net Cash From Operating Activities Net Cash Used In Investing Activities Net Cash Used In Financing Activities 11.324.537.9 7.256.